- Home
- IMTX vs TRIN Comparison
IMTX vs TRIN Comparison
Compare IMTX & TRIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMTX
- TRIN
- Stock Information
- Founded
- IMTX N/A
- TRIN 2007
- Country
- IMTX Germany
- TRIN United States
- Employees
- IMTX N/A
- TRIN N/A
- Industry
- IMTX Biotechnology: Biological Products (No Diagnostic Substances)
- TRIN Finance/Investors Services
- Sector
- IMTX Health Care
- TRIN Finance
- Exchange
- IMTX Nasdaq
- TRIN Nasdaq
- Market Cap
- IMTX 954.2M
- TRIN 786.4M
- IPO Year
- IMTX N/A
- TRIN 2021
- Fundamental
- Price
- IMTX $7.08
- TRIN $14.56
- Analyst Decision
- IMTX Strong Buy
- TRIN Buy
- Analyst Count
- IMTX 4
- TRIN 3
- Target Price
- IMTX $16.67
- TRIN $15.17
- AVG Volume (30 Days)
- IMTX 522.7K
- TRIN 513.7K
- Earning Date
- IMTX 11-18-2024
- TRIN 10-30-2024
- Dividend Yield
- IMTX N/A
- TRIN 14.12%
- EPS Growth
- IMTX N/A
- TRIN 12.74
- EPS
- IMTX N/A
- TRIN 1.72
- Revenue
- IMTX $128,824,447.00
- TRIN $205,164,000.00
- Revenue This Year
- IMTX $90.79
- TRIN $35.45
- Revenue Next Year
- IMTX N/A
- TRIN $18.14
- P/E Ratio
- IMTX N/A
- TRIN $8.38
- Revenue Growth
- IMTX 52.53
- TRIN 20.08
- 52 Week Low
- IMTX $6.99
- TRIN $13.05
- 52 Week High
- IMTX $13.77
- TRIN $15.44
- Technical
- Relative Strength Index (RSI)
- IMTX 27.93
- TRIN 59.51
- Support Level
- IMTX $6.99
- TRIN $14.36
- Resistance Level
- IMTX $7.40
- TRIN $14.70
- Average True Range (ATR)
- IMTX 0.30
- TRIN 0.22
- MACD
- IMTX -0.00
- TRIN -0.00
- Stochastic Oscillator
- IMTX 10.46
- TRIN 76.80
About IMTX Immatics N.V.
Immatics NV is a biotechnology company that is engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies.
About TRIN Trinity Capital Inc.
Trinity Capital Inc is a closed-end, non-diversified management investment company. The company is engaged in providing debt, including loans and equipment financings, to growth-stage companies, including venture-backed companies and companies with institutional equity investors. Its equipment financings involve loans for general or specific use, including acquiring equipment, secured by the equipment or other assets of the portfolio company.